Thiazolidinediones inhibit hepatocarcino
✍
Andrea Galli; Elisabetta Ceni; Tommaso Mello; Simone Polvani; Mirko Tarocchi; Fr
📂
Article
📅
2010
🏛
John Wiley and Sons
🌐
English
⚖ 907 KB
Antidiabetic thiazolidinediones (TZD) have in vitro antiproliferative effect in epithelial cancers, including hepatocellular carcinoma (HCC). The effective anticancer properties and the underlying molecular mechanisms of these drugs in vivo remain unclear. In addition, the primary biological target